Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of antibacterial composition and its application

A composition and compound technology, which is applied in the directions of antibacterial drugs, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of inability to match the half-life of antibiotics, restrictions and other problems

Active Publication Date: 2021-09-10
SHANDONG XUANZHU PHARMA TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] However, avibactam and MK-7655 in clinical T 1 / 2 It is short and cannot be effectively matched with the half-life of antibiotics, which limits its clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of antibacterial composition and its application
  • A kind of antibacterial composition and its application
  • A kind of antibacterial composition and its application

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0197] Compound Synthesis Preparation Example 1 Preparation of (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid

[0198]

[0199] (1) Ethyl (S)-2-((tert-butoxycarbonyl)amino-6-(dimethyl (oxo)-λ 6 Preparation of -thioylide)-5-oxohexanoic acid ester

[0200]

[0201] Dissolve trimethylsulfoxide iodide (343.2g, 1.56mol) into N,N-dimethylformamide (2300mL), add potassium tert-butoxide (156.9g, 1.40mol) in batches, and stir at room temperature for 1 Hour. Add 1-tert-butyl 2-ethyl (S)-5-oxopyrrolidine-1,2-dicarboxylate (350g, 1.36mol) in batches, stir at room temperature for 2 hours after the addition, add water (4000mL ), extracted with ethyl acetate (3000mL × 5), the organic phases were combined, washed with saturated brine (3000mL), dried over anhydrous sodium sulfate, concentrated, and the crude product was subjected to silica gel column chromatography (dichloromethane:methanol=10: 1) Purification gave the title compound (280 g, yield 59%) as ...

preparation example 2

[0225] Preparation Example 2 Preparation of tert-butyl 6-hydroxyl-2-azaspiro[3.3]heptane-2-carboxylate

[0226]

[0227] Add tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate (4.22g, 20mmol) into methanol (30mL), lower the temperature to 0°C under nitrogen protection, add hydroboration Sodium (1.52g, 40mmol), after the addition was completed, the temperature was raised to 25°C and stirred for 1 hour. LC-MS detected that the reaction was complete, and water (1mL) was added to quench the reaction. The solvent was evaporated under reduced pressure, and water (100mL) and ethyl acetate ( 100 mL), liquid separation, the organic phase was washed with hydrochloric acid (1mol / L, 50 mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated to give the white title compound (4.0 g, yield 93.7%).

preparation example 3

[0228] Preparation Example 3 Preparation of tert-butyl 6-(1,3-dioxoisoindoline-2-yl)-2-azaspiro[3.3]heptane-2-carboxylate

[0229]

[0230] Under nitrogen protection, tert-butyl 6-hydroxyl-2-azaspiro[3.3]heptane-2-carboxylate (4.0g, 18.8mmol), phthalimide (3.86g, 26.2mmol) and triphenylphosphine (5.92g, 22.6mmol) were added to tetrahydrofuran (100mL), the temperature was lowered to 0°C, diethyl azodicarboxylate (3.93g, 22.6mmol) was slowly added dropwise, and the temperature was raised to 25 °C and stirred for 16 hours. LC-MS detected that the reaction was complete, adding water (1mL) to quench the reaction, concentrating the solvent under reduced pressure, adding water (150mL) and ethyl acetate (150mL), separating the layers, extracting the aqueous phase with ethyl acetate (100mL×2), combining the organic phase, concentrated, and the crude product was purified by silica gel column chromatography (petroleum ether: ethyl acetate = 10:1) to obtain the white title compound (6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of medical technology, and specifically designs a composition comprising compound (a), its pharmaceutically acceptable salt, its ester, its solvate or its stereoisomer, and at least one carbapenem antibiotics or derivatives thereof, wherein the compound (a) has the structure shown in formula (I). The present invention also relates to the use of the composition for preventing and / or treating infectious diseases caused by bacteria, preferably, the bacteria have drug resistance caused by β-lactamase.

Description

technical field [0001] The present invention relates to a composition and its pharmaceutical use, in particular to an antibacterial composition comprising a diazabicyclooctone compound and a carbapenem antibiotic, and the antibacterial composition is used in the preparation of treatment and / or prevention of bacterial infection use in infectious diseases. Background technique [0002] The rapid development of antibiotics is of great significance in the history of modern medicine. However, antibiotic resistance, especially the resistance of Gram-negative bacteria, is becoming more and more serious, which has seriously threatened human health. Worryingly, the current bacterial drug resistance shows a trend of multidrug resistance (MDR) and pan-drug resistance (PDR), which makes patients lack effective treatment options when facing severe bacterial infections, Thereby endangering the life safety of the patient. In Europe, the number of deaths caused by antibiotic resistance i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/439A61K31/407A61P31/04
CPCA61K31/407A61K31/439A61K2300/00
Inventor 盛泽娟张宝成高聪范秀君王田园
Owner SHANDONG XUANZHU PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com